Melanoma Cell Factory for Glycolipid Production by Maria Carmelita Z. Kasuya & Kenichi Hatanaka
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
6 
Melanoma Cell Factory for  
Glycolipid Production 
Maria Carmelita Z. Kasuya and Kenichi Hatanaka 
Institute of Industrial Science, The University of Tokyo 
Japan 
1. Introduction 
Glycolipids are ubiquitous in membranes of biological systems and play crucial roles in cell 
surface events including cell proliferation, differentiation, transmembrane signaling, cell-cell 
interactions, cell recognition, motility and cell - substrate interactions such as embryogenesis, 
inflammation and carcinogenesis (Hakomori, 1981; Kolter, 2002; Varki, 1999). Glycolipids, 
particularly gangliosides, mediate cell adhesion and modulate signal transduction. 
Gangliosides, cell surface glycolipids with at least one sialic acid residue, are located at the 
outer cell-surface of plasma membranes (Gervay et al., 1993). They are found predominantly 
in the nervous system where they constitute about 10% of all phospholipids. Gangliosides 
have also been detected in the liver of several species of shark, rat kidney, cerebelum of 
chicken, mouse erythrocytes, human brain and in human melanoma tumors (Li, 2002; 
Ozawa, 1993; Saito, 1982). 
Gangliosides are involved in several diseases such as Tay-Sachs disease and Guillan-Barré 
syndrome. Impaired ganglioside metabolism is also relevant to Alzheimer’s disease. 
Gangliosides bind specifically to virus such as influenza virus and various toxins such as 
tetanus, cholera and botulinum (Prichet & Paulson, 1989; Sun, 2000; Suzuki, 1990). 
Gangliosides are also implicated in skin cancer. Human melanoma cells overexpress 
ganglioside (Freeze et al., 1993). Normal melanocytes predominantly express GM3 (greater 
than 90%) and GD3 (less than 5%) (Hoon 1988, 1992). However, malignant melanoma 
expresses other types of gangliosides including GM2 and GD2. Human melanoma cells 
express the four major gangliosides (GM3, GD3, GM2 and GD2). 
Considering the essential roles played by glycolipids in biochemical and cellular processes, 
development of methods for their rapid and efficient synthesis is necessary. Isolation from 
natural sources affords glycolipids but with very limited amounts. The conventional 
chemical synthetic approach gives glycolipids with high purity in good yield. However, the 
poor stereoselectivity and the multi-step operation involving tedious protection and 
deprotection schemes are among the many shortcomings. Enzyme synthesis promises high 
levels of regioselectivity and stereoselectivity but the availability and high cost have to be 
reckoned with. 
As part of our continued interest in the synthesis of glycolipids, the saccharide primer strategy 
was employed as a viable alternative to existing methods (Kasuya, 2000, 2004, 2005, 2007, 
2010a, 2010b, 2010c, 2010d; Sato, 2007). The saccharide primer method using animal cells 
and amphiphilic glycoside primers such dodecyl α- and β-lactoside, 12- and 2-azidododecyl 
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lactosides, dodecyl α- and β-galactoside, dodecyl α- and β-glucoside, thiolactosides, glycosides 
with perfluoroalkyl chains and fluorinated galactoside was developed for the fast, simple 
and convenient synthesis of glycolipids. The saccharide primers were chemically synthesized 
and introduced into mouse melanoma B16 cells to generate GM3- and GM4-type 
gangliosides in fairly good yield.  
For the production of ganglioside such as GM3 (NeuAcα3Galβ4Gluβ1Cer), mouse 
melanoma B16 cell is a good candidate to produce chemical quantities with homogeneity 
required for application since cancer cells proliferate even beyond confluency due to the 
absence of contact inhibition. Mouse melanoma B16 cells in culture could serve as the “cell 
factory” where the raw material (saccharide primer) is processed by endogenous donors 
and enzymes to generate products, biologically important glycolipids, with high stereo- and 
regioselectivity. By employing mouse melanoma B16 cells, production of desired 
ganglioside analogues, such as GM3 and GM4, via saccharide primer strategy is possible. 
This chapter presents the versatiliy of melanoma B16 cells for the convenient production of 
glycolipids via saccharide primer strategy. 
2. Saccharide primer method 
The saccharide primer strategy (shown in figure 1) combines chemical synthetic methods 
with cellular biosynthetic processes for the synthesis of glycolipids. The basic building 
blocks, called saccharide primers, are synthetically accessible amphiphilic glycosides that 
resemble lactosyl ceramide, the intermediate in the biosynthetic pathway (Miura & 
Yamagata, 1997). When introduced to cells, the lactosyl ceramide analogues with a single 
lipophilic chain serve as substrate for cellular-mediated glycosylation to afford 
oligosaccharide with glycan structures exactly the same as those produced by the cells used 
(Sarkar 1995, 1997, 2000). By using different types of cells, a library of biologically important 
glycolipids can be generated from one kind of saccharide primer. 
 
uptake
release
Saccharide chain elongation
Saccharide primer  Various glycolipids
Golgi
Animal cells
 
Fig. 1. Saccharide primer strategy 
The basic requirements for the saccharide primer method are the appropriate cell line and 
the amphiphilic saccharide primer. Cells are treasuries of glycosyltransferases and glycosyl 
donors. Careful choice of cells is important because the kind of cells employed will 
determine the structure of the products formed. For mass production, the cell must be 
amenable to continuous culture for several days. The amphiphilic saccharide primer, 
substrate for cellular mediated glycosylation, consists of a saccharide head (hydrophilic 
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moiety) and an alkyl tail (hydrophobic moiety). It is accessible in a few steps through simple 
chemical synthesis. Generally, the saccharide primers can be prepared by conventional 
methods of glycosylation of an alcohol with a glycoside derivative followed by deacylation 
under Zemplen conditions.  
The cellular uptake of primer and release of glycosylated products by cells depend on the 
hydrophobic (aglycon moiety) and hydrophilic (saccharide moiety) balance. The appropriate 
chain length of the aglycon moeity is an important consideration to ensure the efficient 
uptake by cells, glycosylation and release of products to the culture medium for collection. 
A short aglycon unit such as an octyl group does not allow incorporation of the primer into 
the cells. On the other hand, a long aglycon unit such as a stearyl group allows entry into 
cells but the products are not released into the culture medium. The dodecyl aglycon is the 
most appropriate length to ensure uptake, elongation and release of product as shown in 
figure 2 (Nakajima et al., 1998).  
 
uptake
release
X
X
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Fig. 2. Effect of alkyl chain length on saccharide primer uptake and release of product 
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Fig. 3. Cellular enzyme-mediated glycosylation of saccharide primer 
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For priming to occur, the saccharide primers must pass through the plasma membrane and 
enter the Golgi, where the glycosyltransferases reside and where glycosylation takes place 
(Kolter et al., 2002). After diffusion through the cell membrane, the saccharide primers are 
assimilated into the glycosphingolipid biosynthetic pathway and function as acceptor for 
the glycosyl transferases. The sugar nucleotide donor and the glycosyl transferase are both 
endogenously prepared by the cells. When administered into animal cells such as mouse 
melanoma B16 cells, a lactoside primer functions as acceptor for the GM3 synthase, α-(2→3) 
sialyl transferase, resulting in sialylation of the terminal galactosyl residue of the lactosyl 
moiety to afford a GM3-type glycolipid as shown in figure 3. 
2.1 Methodology 
The important steps in glycolipid production using melanoma B16 cells via saccharide 
primer method include (1) chemical synthesis of saccharide primer, (2) administration, 
cellular uptake and glycosylation of saccharide primer, (3) lipid extraction, (4) analysis of 
products, and (5) structure elucidation of product (figure 4).  
 
48-h incubation,  37 oC,  5% CO2
Chemical synthesis of  
   saccharide primer
Control Treated
in DMSODMSO+
B16 cells B16 cells
HPTLC Analysis
Cell fraction Medium fraction
Medium fraction
Cell fraction
Lipid extraction
CHCl3:MeOH:0.25% KCl ( 5:4:1)
CHCl3:MeOH, 2:1
CHCl3:2-propanol:H2O, 7:11:2
Sonication, 30 min
CHCl3:MeOH, 2:1
SepPak Cartridge
DMEM-F12 supplemented with ITS-X 100 % MeOH
Treatment with enzymes
Structure elucidation of
glycosylated product
Mass spectral analysis
Administration of saccharide primer
 
Fig. 4. General method for glycolipid production via saccharide primer strategy 
2.1.1 Chemical synthesis of saccharide primers 
Generally, the saccharide primers are prepared in 2 steps: glycosylation of an alcohol with a 
monosaccharide (peracetylated galactose or glucose) or a disaccharide (peracetylated 
lactose) derivative followed by deacylation. Glycosylation is carried out using Lewis acid 
such as BF3·OEt2 as catalyst. The β-linked product is separated by column chromatography. 
Deacylation under Zemplen conditions using sodium methoxide and methanol affords the 
desired saccharide primers that could be purified by recrystallization using methanol. The 
structure of the saccharide primers is confirmed from the NMR and mass spectral results. A 
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50 mM stock solution is prepared by dissolving the saccharide primer in sterile 
dimethylsulfoxide (Me2SO). 
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2.1.2  Administration, cellular uptake and glycosylation 
Inocula of 2 x 106 of mouse melanoma B16 cells are cultured in 100-mm dishes containing  
7 mL of 1:1 DMEM-F12 supplemented with 10% fetal bovine serum (FBS) and maintained in 
humidified atmosphere of 5% CO2 air at 37 °C for 48 h. Then, cells are washed twice with 
medium supplemented with insulin-transferrin-selenium X (ITS-X) solution to remove the 
serum, and then incubated with 50 μM of the saccharide primer for 48 h at 37 °C. During 
incubation of cells in the presence of primer, uptake and subsequent elongation by cellular 
enzymes take place to afford products that are released to the culture medium.  
2.1.3 Extraction of lipids and structure elucidation of product   
After incubation in the presence of primer, the culture media and cells are collected.  
The lipids are extracted from the cell pellet with CHCl3 : MeOH (2 : 1, v/v), then with  
CHCl3 : 2-propanol : water (7 : 11 : 2, v/v), in a sonicated bath. On the other hand, the  
lipids from the culture media are purified using SepPak C18 column. Lipids from the  
cell homogenate and culture medium fractions are analyzed by HPTLC with  
CHCl3 : MeOH : 0.2 % aq KCl (5 : 4 : 1, v/v) as developing solvent. HPTLC plates are 
sprayed with resorcinol (Svennerholm, 1957), then with orcinol-H2SO4 reagent, and heated 
(120 °C) to detect the products of glycosylation. The putative bands corresponding to 
glycosylated primers are scraped from HPTLC plate, extracted with methanol and analyzed. 
The structure of the product is elucidated from the results of mass spectral analysis and 
enzyme hydrolysis. 
3. Glycolipid production using various kinds of saccharide primers 
3.1 Dodecyl glucoside, galactoside and lactoside primers 
The saccharide primers are analogues of lactosyl ceramide, the natural precursor for the 
biosynthesis of glycolipids. Although the hydrophilic moieties are the same, the saccharide 
primers have a single hydrophobic tail, a dodecyl aglycon unit. Preliminary work focused 
on n-dodecyl β-lactoside primer that is structurally, the closest analogue to the natural 
precursor (Miura & Yamagata, 1997; Nakajima, 1998). n-Dodecyl β-lactoside primer does not 
have adverse effects on viability and morphology of melanoma B16 cells at an initial 
concentration of 50 μM. Cytotoxicity becomes prevalent at higher concentrations. Incubation 
of mouse melanoma B16 cells in the presence of dodecyl lactoside primer gave a GM3-type 
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glycolipid (shown in Table 2) that was mostly found in the culture medium fraction. To 
determine whether primers with monosaccharide residue would have the same effect on 
B16 cells on glycolipid production, glucoside and galactoside primers with the same 
dodecyl aglycon unit were also prepared and administered into B16 cells (Kasuya et al., 
2005). 
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Dodecyl  β-D-glucoside
 
Table 1. Cell number after 48-h incubation of cells with the saccharide primer. 
As shown in table 1, the growth of melanoma B16 cells in the presence of β-lactoside was 
similar to that of control indicating that the lactoside primer does not express remarkable 
toxicity towards the cells at 50 μM concentration. However, the monosaccharide primers 
exhibited cytotoxicity to a certain extent. Relative to control, dodecyl galactoside primer 
reduced the cell number by almost half while dodecyl glucoside primer was cytotoxic. 
Although the galactoside primer exhibited moderate cytotoxicty, the galactoside primer 
passed through the plasma membrane and was assimilated in the glycosphingolipid 
biosynthetic pathway to function as acceptor for α-(2→3)-sialyl transferase, resulting in the 
direct glycosylation occurring at the galactosyl residue to afford a GM4-type glycolipid as 
shown in Table 2. Expectedly, the β-glucoside primer that expressed cytotoxicity (90 % of 
the cells died) was not elongated. 
3.2 α- and β-linked saccharide primers 
Whether or not the glycosidic linkage of the aglycon unit of saccharide primers affects the 
production of glycolipids by melanoma B16 cells was also investigated. Dodecyl α- and  
β- lactoside, dodecyl α- and β-galactoside, dodecyl α- and β-glucoside were chemically 
synthesized and introduced to mouse melanoma B16 cells (Kasuya et al., 2005).  
The assimilation of primers into cells through the plasma membrane seemed to be 
unaffected by the anomeric linkage. Regardless of the α- or β-linkage to the aglycon unit, 
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Table 2. Results after 48-h incubation of melanoma B16 cells with 50 μΜ α- or β- linked 
saccharide primers. 
melanoma B16 cells take in the primers. However, elongation occurred only with dodecyl α- 
and β-lactoside, and dodecyl β-galactoside primers to afford GM3- and GM4-type 
oligosaccharides, respectively as shown in Table 2. In cellular sialylation, a terminal 
galactose residue that is β-linked to the adjacent saccharide or aglycon unit is necessary. 
Sialyltransferases reside in the Golgi compartment and transfer a sialic acid residue from 
CMP-sialic acid to the C-6 or C-3 hydroxyl group at the non-reducing Gal-, Gal NAc-, or 
GlcNAc residue. For glycosylation of primers by cells to occur, the glycoside must diffuse 
through the plasma membrane and enter the Golgi. The anomeric linkage of the aglycon 
unit seems irrelevant for primer incorporation into melanoma B16 cells. However, the 
anomeric β-linkage of the terminal galactoside residue that is the site for sialylation of the 
primers is significant for elongation. 
3.3 Thiolactoside primers 
Sulfur containing compounds have various applications in the pharmaceutical industry and 
in synthetic chemistry as glycosyl donors for the synthesis of complex oligisaccharides 
(Castaneda, 2007; Codee, 2005; Garegg, 1997; Krag, 2010; Witzak, 2005). Thiolactosides 
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having a lactose moiety linked to a hydrophobic dodecyl aglycon unit via S-glycosidic bond 
have also been prepared and administered into mouse melanoma B16 cells (Mori et al., 
2011).  
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Cellular uptake of either n-dodecyl β-thiolactoside (β-LacSC12) or n-dodecyl α-thiolactoside 
(α-LacSC12) afforded GM3-type glycolipid. Noteworthy is that the sialyl transferases 
residing in the Golgi of melanoma B16 cells also recognized and elongated the primer with 
an S-glycoside linkage.  
Interestingly, the addition of the thiolactoside primers resulted to a remarkable change on 
melanoma B16 cell morphology. Although B16 cells are epidermoid, cells became elongated 
and acquired a slender shape that is similar to fibroblast cells in the presence of thiolactoside 
primers (Figure 5). Significantly, increased melanin secretion was observed from B16 cells 
incubated in the presence of α-LacSC12 primer as evidenced by the brown coloration of the 
culture medium collected. The α-linked thiolactoside possibly inflicted stress on the 
melanoma B16 cells resulting to elevated production of the pigment melanin. As a natural 
response to stimuli, the skin produces melanin to protect from damage. Melanoma B16 cells 
increased production of the pigment to protect the cells from damage in the presence of the 
α-linked thiolactoside. Coloration of the culture medium was observed in the following 
order: α-LacSC12 > control > β-LacSC12. 
 
 
                Control                                      α-LacSC12                                      β-LacSC12 
Fig. 5. Effect of thiolactoside primers on morphology of melanoma B16 cells. 
3.4 2-Azido and 12-azido dodecyl lactoside primers 
In view of the biological significance and potential application attached to the products 
obtained via saccharide primer method, it is essential that the saccharide primer should still 
be amenable to further modification after elongation. A functional group such as an azide is 
excellent for the preparation of glycopolymers and glycoconjugates. After internalization 
and glycosylation of saccharide primers by cells, the azido group at the aglycon can be 
selectively reduced to an amino group and conjugated for the synthesis of functional 
polymers.  
Two types of saccharide primers, 12-azidododecyl β-lactoside and 2-azidododecyl β-
lactoside were prepared and introduced to melanoma B16 cells (Kasuya, 2000; Murozuka, 
2005). These primers were designed with the azido group at different positions in the 
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aglycon unit to determine the effect of the position of the functional group on cellular 
uptake and glycolipid production.  
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Incubation with 50 μM of either 12-azidododecyl β-lactoside or 2-azidododecyl β-lactoside 
primers has no inherent damage to cells. Expectedly, melanoma B16 cells incorporated and 
elongated both primers to give GM3-type oligosaccharide that was mostly secreted in the 
culture medium. Like the rest of the primers used, the azidododecyl lactoside primers also 
inhibited the synthesis of endogenous GM3. The limited amount or capability of 
endogenous sialyltransferases possibly accounts for the inhibition.  
Although both primers could be taken up by cells and transported to the Golgi, the 
glycosylation site, the relative ability to pass through the membrane and be recognized as 
substrate for sialyl transferases is different. The 2-azidododecyl β-lactoside could pass 
through the plasma membrane with relative ease than 12-azidododecyl β-lactoside. 
Consequently, the amount of product obtained from 2-azidododecyl β-lactoside (14% yield) 
was higher than the 12-azidododecyl β-lactoside (7.6% yield) under the same conditions. 
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3.5 Fluorous-tagged saccharide primers  
The interplay between the hydrophilic and hydrophobic balance brought about by the 
saccharide residue and the aglycon unit, respectively, is an important factor in glycolipid 
production using amphiphilic glycosides and melanoma B16 cells. This was demonstrated 
by using saccharide primers with various perfluoroalkyl aglycon units.  
A series of lactosides with different perfluoroalkyl chain [LacH6F6 (each number indicates 
the number of CH2 and CF2, respectively), LacH2F8, LacH3F8, LacH2F10] were chemically 
synthesized and introduced to mouse melanoma B16 cells (Kasuya 2010a, 2010b, 2010c). 
After 48-h incubation, results showed that primers did not affect cell morphology and 
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viability at a concentration of 50 μM. Moreover, the numerous fluorine atoms did not pose a 
steric barrier to primer assimilation into cells. The fluorous-tagged lactoside primers were 
sialylated to afford GM3-type glycolipid that was mostly found in the culture medium.  
Although the length of the aglycon unit subscribed to the recommended chain length, 
dodecyl (C12), to ensure efficient uptake and release of products, the amount of glycolipids 
produced and the amount of fluorous-tagged saccharides remaining in the cells varied 
depending on hydrophobicity that is attributed mainly on the fluorine content. Increasing 
the fluorine content renders the fluorous-tagged saccharide primers to be more hydrophobic 
(Kasuya et al., 2010). As shown in figure 6, as the fluorine content of the perfluoroalkyl tail 
increases, the amount of lactoside primer in the cells also increases. On the other hand, an 
increase in the fluorine content results to a decrease in the amount of product. Lac H2F10 
with the highest fluorine content gave the least amount of product. Lac H6F6 having the 
least number of fluorine atoms gave the highest amount among the fluorous-tagged 
lactoside primers. Significantly, a relatively large amount of Lac H2F10, most hydrophobic 
among the fluorous-tagged primers used, was found in the cell fraction. Considering the 
immiscibility of fluorous layer with neither an aqueous nor an organic layer, it is 
noteworthy that the saccharide primers with perfluoroalkyl tail have a strong affinity for the 
lipid-rich cell membrane. 
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Fig. 6. Glycolipid production using saccharide primers with various perfluoroalkyl chains 
3.6 Fluorinated galactoside primers 
Ganglioside GM4 exhibits interesting biological activities. The challenging synthetic 
consideration that involves the regio- and stereoselective incorporation of sialic acid 
propelled the preparation of GM4 analogues by the saccharide primer strategy. This was 
achieved using dodecyl β-galactoside primer and mouse melanoma B16 cells. The 
replacement of a hydroxyl group by fluorine atom in the galactose residue was also pursued 
not only to prepare fluorinated GM4 analogues but also to establish the effect of the fluorine 
atom in the saccharide residue on melanoma B16 cells and glycosylation.  
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Fluorinated galactosides with dodecyl aglycon, 2F Gal, 4F Gal and 6F Gal, were chemically 
synthesized (Card & Reddy, 1983; Dax et al., 2000) and administered to mouse melanoma 
B16 cells to verify their potential as scaffolds for the synthesis of a GM4 analogue (Kasuya et 
al., 2007). Among the 3 kinds of primers, 2F Gal did not affect cell morphology and viability. 
In contrast, 4F Gal primer exhibited slight cytotoxicity and 6F Gal primer was cytotoxic at 50 
μM concentration. The HPTLC results of the lipids obtained from the cell and culture 
medium fractions confirmed that the primers were taken-up by the cells but only the 2F Gal 
was glycosylated and the elongated product released to the culture medium. The MALDI 
TOF mass spectral results and treatment of the product with 2,3-sialidase (cloned from S. 
typhimurium LT2 and expressed in E. coli) confirmed the structure of the glycosylation 
product, a GM4 analogue. 
 
     
                     2F Gal                                           4F Gal                                           6F Gal 
 
The presence of a fluorine atom was expected to have minimal effect on cell viability and 
primer assimilation into cells that may be attributed to the size and hydrophobicity of 
fluorine. However, replacement of one hydroxyl unit by a fluorine atom in different 
positions of the galactose residue elicited different cellular responses. A fluorine atom at 2 
position of the galactose residue did not have adverse effects to the cell, and 2F Gal was 
glycosylated. However, a fluorine atom at 4 or 6 positions slightly, or greatly, affected cell 
viability. As a consequence, saccharide elongation of 4F and 6F Gal primers did not take 
place. Although sialyl transferases are amenable to substrate modifications, the type and 
position of substituent at the vicinity of the glycosylation site (C3 position) and their positive 
effect on cell viability are prerequisites for cellular enzyme glycosylation and substrate 
recognition by 2,3-sialyl transferase.  
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4. Mass production  
For the mass production of gangliosides via saccharide primer method, the choice of cell to 
be employed is crucial. The cells to be used should be amenable to continuous culture for 
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several days that requires repeated administration of primer and harvest of culture medium. 
Moreover, cells should provide the desired glycolipid in fairly good yield. Mouse melanoma 
B16 cells meet these requirements for the production of ganglioside analogues. Other 
considerations for the mass production of gangliosides include optimization of seeded cell 
number, length of incubation time and primer concentration (Miyagawa et al., 2007). 
Saccharide primers are cytotoxic when introduced to a small number of seeded cells as 
compared to a large number of cells due to the existence of stronger intercellular connection 
at the confluent state of cells. Generally, the higher the seeded cell number, the more 
product obtained.  
The optimum length of incubation time is 48 h. Although the amount of glycosylated 
product increases linearly with respect to the length of incubation time, productivity does 
not significantly advance beyond 48-h incubation. Moreover, long exposure to saccharide 
primers affects cellular morphology.  
The amount of sialylated primer increases linearly with increasing concentration while 
consequently inhibiting endogenous GM3 production. However, beyond the optimum 
concentration is cytotoxic. 
4.1 GM4-type glycolipid 
The simplest among the gangliosides is sialylgalactosyl ceramide GM4 (NeuAcα2→3GalCer) 
(Bazin, 1999; Gervay, 1993). GM4 is a minor ganglioside in human brain and has been 
detected in human myelin and human oligodendrocytes. However, the biological 
significance remains unknown. GM4 is scarce in natural sources so chemical and enzymatic 
synthesis remains to be the viable sources of quantitative amounts of GM4 (Otsubo, 2001; 
Satoh, 1996; Schnaar, 1998). 
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The utility of the saccharide primer method for the mass production of GM4-type 
ganglioside (Kasuya et al., 2010) was carried out. The optimum conditions for the mass 
production of GM4-type ganglioside by the saccharide primer method of employing mouse 
melanoma B16 cells and dodecyl β-galactoside primer (Gal C12) included: seeded cell 
number (5 x 106, 15 cm dishes, 20 mL medium), concentration (50 μM) and incubation time 
(48 h or 72 h). Based on HPTLC results, more GM4 could be obtained from higher 
concentration of primer, 100 or 150 μM, but slight to moderate cytotoxicity was observed. 
Hence, 50 μM was administered to cells to ensure continuous culture requiring repeated 
administration of primer and harvest of culture medium.  
GalC12 did not exhibit adverse effects on cell morphology and viability. However, 
formation of colonies became evident during the second week of incubation. Cells continue 
to glycosylate the primer but the amount produced decreased after repeated primer 
administration and harvest. The culture media containing the product from all the harvests 
were pooled and the glycolipids were adsorbed on HP20 resin and eluted with gradient 
MeOH. Purification of the products was accomplished using SepPak columns. Finally, 
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purification by Centrifugal Partition Chromatography (CPC) (Kato et al., 2007) gave 4.0 mg 
of the GM4 analogue with high purity from 4.2 liters of culture medium.  
5. Conclusion 
In the production of glycolipids such as GM3- and GM4-type gangliosides, melanoma B16 
cells could serve as the “cell factory” that processes the saccharide primers such dodecyl  
α- and β-lactoside, 2- and 12-azidododecyl lactosides, dodecyl β-galactoside, fluorinated 
galactoside, thiolactosides or glycosides with perfluoroalkyl chains and transforms them to 
GM3- and GM4-type gangliosides using endogenous enzymes and glycosyl donor. 
Generally, monosaccharide and disaccharide primers gave GM4- and GM3-type glycolipids, 
respectively. 
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With a few exceptions, the galactoside and lactoside primers reported in this chapter (1) do 
not have adverse effects on morphology and viability of mouse melanoma B16 cells at 50 
μM after incubation for 48 h, (2) are taken in by melanoma B16 cells and assimilated to the 
Golgi, the site of glycosylation, and (3) are recognized by cellular enzymes and elongated to 
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afford glycolipids that are released to the culture medium for collection, purification and 
identification. By employing mouse melanoma B16 cells, production of biologically 
important glycolipids via saccharide primer method is fast, convenient and highly 
stereoselective. Significantly, expensive enzymes and glycosyl donor are no longer 
necessary since these are endogenous to melanoma B16 cells. Melanoma B16 cells is a good 
candidate in the mass production of glycolipids, particularly GM3- and GM4-type 
gangliosides, because it is amenable to continuous culture for several days.  
Depending on the type of saccharide primer and the concentration administered into 
melanoma B16 cells, the various effects such as elevated pigmentation, alteration of cell 
morphology, and decreased production of endogenous glycolipids, the saccharide primer 
strategy offers a fresh approach to understanding the molecular and cellular mechanism 
underlying the pathogenesis of melanomas. Moreover, the saccharide primer strategy could 
open possibilities for new therapeutic options for melanoma.  
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